CIK 0001885522
- Non-accelerated filer
- Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 844367680
- Phone
- +1 857-760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 399,291 shares (gift)
- 4 Planned sale Director sold 21,788 shares at an average $17.03 ($370,962)
- 4 Planned sale Head of R&D sold 13,823 shares at an average $15.06 ($208,110)
- 4 Planned sale Head of R&D sold 41,464 shares at an average $11.89 ($492,827)
- 4 Planned sale Head of R&D sold 32,948 shares at $11.43 ($376,665)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 15,693 shares at $11.39 ($178,806)
- 4 Planned sale Chief Financial Officer sold 84,307 shares at an average $11.67 ($984,061)
- 4 Gift Chief Financial Officer gave 238,965 shares (gift)
Page 3 of 6 · 118 filings